Last 12 months
Inside the activity.
0 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 05, 2026 Filed Sep 9, 2026 22:42 UTC |
SCHWARTZ NORMAN DDirector · Chairman & CEO · 10% owner
|
Exercise / conversionBio-Rad A Common Stock | 4,109 | $0.00 | $0.00 |
DisclosureSEC source: 0000940805-26-000004 · wk-form4_1788993728.xml · nonDerivative · entry 1 SCHWARTZ NORMAN D · CIK 0000940805 · Director · Chairman & CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 450,294 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 04, 2026 Filed Sep 9, 2026 22:47 UTC |
Allison SchwartzDirector
|
GrantRestricted Stock Units · Derivative | 719 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001924980-26-000004 · wk-form4_1788994034.xml · derivative · entry 5 Allison Schwartz · CIK 0001924980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 719 Underlying: Bio-Rad A Common Stock · 719 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F3 · derivative.exercise_date: The restricted stock units vest over four years, with 25% vesting on the first anniversary of the grant date and the remaining units vesting in equal quarterly installments thereafter. F3 · derivative.expiration_date: The restricted stock units vest over four years, with 25% vesting on the first anniversary of the grant date and the remaining units vesting in equal quarterly installments thereafter. Read SEC document |
| September 04, 2026 Filed Sep 9, 2026 22:46 UTC |
BARRY JAMESEVP, President, LSG
|
GrantRestricted Stock Units · Derivative | 4,313 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0002022345-26-000004 · wk-form4_1788994011.xml · derivative · entry 5 BARRY JAMES · CIK 0002022345 · EVP, President, LSG 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,313 Underlying: Bio-Rad A Common Stock · 4,313 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F3 · derivative.exercise_date: The restricted stock units vest over four years, with 25% vesting on the first anniversary of the grant date and the remaining units vesting in equal quarterly installments thereafter. F3 · derivative.expiration_date: The restricted stock units vest over four years, with 25% vesting on the first anniversary of the grant date and the remaining units vesting in equal quarterly installments thereafter. Read SEC document |
| September 04, 2026 Filed Sep 9, 2026 22:46 UTC |
EVRAN SEDATEVP, Global Supply Chain
|
GrantRestricted Stock Units · Derivative | 4,026 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001993147-26-000002 · wk-form4_1788993983.xml · derivative · entry 5 EVRAN SEDAT · CIK 0001993147 · EVP, Global Supply Chain 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,026 Underlying: Bio-Rad A Common Stock · 4,026 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F4 · derivative.exercise_date: The restricted stock units vest over four years, with 25% vesting on the first anniversary of the grant date and the remaining units vesting in equal quarterly installments thereafter. F4 · derivative.expiration_date: The restricted stock units vest over four years, with 25% vesting on the first anniversary of the grant date and the remaining units vesting in equal quarterly installments thereafter. Read SEC document |
| September 04, 2026 Filed Sep 9, 2026 22:45 UTC |
ENGELHARDT EVA ANETTEEVP, President, CDG
|
GrantRestricted Stock Units · Derivative | 4,313 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0002024911-26-000006 · wk-form4_1788993956.xml · derivative · entry 5 ENGELHARDT EVA ANETTE · CIK 0002024911 · EVP, President, CDG 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,313 Underlying: Bio-Rad A Common Stock · 4,313 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F3 · derivative.exercise_date: The restricted stock units vest over four years, with 25% vesting on the first anniversary of the grant date and the remaining units vesting in equal quarterly installments thereafter. F3 · derivative.expiration_date: The restricted stock units vest over four years, with 25% vesting on the first anniversary of the grant date and the remaining units vesting in equal quarterly installments thereafter. Read SEC document |
| September 04, 2026 Filed Sep 9, 2026 22:45 UTC |
DiVincenzo Jonathan P.President & COO
|
GrantRestricted Stock Units · Derivative | 6,326 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001453524-26-000002 · wk-form4_1788993926.xml · derivative · entry 3 DiVincenzo Jonathan P. · CIK 0001453524 · President & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,326 Underlying: Bio-Rad A Common Stock · 6,326 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F3 · derivative.exercise_date: The restricted stock units vest over four years, with 25% vesting on the first anniversary of the grant date and the remaining units vesting in equal quarterly installments thereafter. F3 · derivative.expiration_date: The restricted stock units vest over four years, with 25% vesting on the first anniversary of the grant date and the remaining units vesting in equal quarterly installments thereafter. Read SEC document |
| September 04, 2026 Filed Sep 9, 2026 22:45 UTC |
ENLOE COURTNEY CEVP, General Counsel & Sec
|
GrantRestricted Stock Units · Derivative | 2,876 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0002019843-26-000004 · wk-form4_1788993899.xml · derivative · entry 5 ENLOE COURTNEY C · CIK 0002019843 · EVP, General Counsel & Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,876 Underlying: Bio-Rad A Common Stock · 2,876 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F3 · derivative.exercise_date: The restricted stock units vest over four years, with 25% vesting on the first anniversary of the grant date and the remaining units vesting in equal quarterly installments thereafter. F3 · derivative.expiration_date: The restricted stock units vest over four years, with 25% vesting on the first anniversary of the grant date and the remaining units vesting in equal quarterly installments thereafter. Read SEC document |
| September 04, 2026 Filed Sep 9, 2026 22:44 UTC |
Mehta RajatEVP, GBL Commercial Operations
|
GrantRestricted Stock Units · Derivative | 4,601 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0002081681-26-000002 · wk-form4_1788993866.xml · derivative · entry 5 Mehta Rajat · CIK 0002081681 · EVP, GBL Commercial Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,601 Underlying: Bio-Rad A Common Stock · 4,601 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F4 · derivative.exercise_date: The restricted stock units vest over four years, with 25% vesting on the first anniversary of the grant date and the remaining units vesting in equal quarterly installments thereafter. F4 · derivative.expiration_date: The restricted stock units vest over four years, with 25% vesting on the first anniversary of the grant date and the remaining units vesting in equal quarterly installments thereafter. Read SEC document |
| September 04, 2026 Filed Sep 9, 2026 22:42 UTC |
Lakkaraju Roop KalyanEVP, Chief Financial Officer
|
GrantRestricted Stock Units · Derivative | 6,326 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001396867-26-000004 · wk-form4_1788993769.xml · derivative · entry 5 Lakkaraju Roop Kalyan · CIK 0001396867 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,326 Underlying: Bio-Rad A Common Stock · 6,326 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F4 · derivative.exercise_date: The restricted stock units vest over four years, with 25% vesting on the first anniversary of the grant date and the remaining units vesting in equal quarterly installments thereafter. F4 · derivative.expiration_date: The restricted stock units vest over four years, with 25% vesting on the first anniversary of the grant date and the remaining units vesting in equal quarterly installments thereafter. Read SEC document |
| September 04, 2026 Filed Sep 9, 2026 22:42 UTC |
SCHWARTZ NORMAN DDirector · Chairman & CEO · 10% owner
|
GrantRestricted Stock Units · Derivative | 17,251 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000940805-26-000004 · wk-form4_1788993728.xml · derivative · entry 15 SCHWARTZ NORMAN D · CIK 0000940805 · Director · Chairman & CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,251 Underlying: Bio-Rad A Common Stock · 17,251 shares Expires not disclosed F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F6 · derivative.exercise_date: The restricted stock units vest over four years, with 25% vesting on the first anniversary of the grant date and the remaining units vesting in equal quarterly installments thereafter. F6 · derivative.expiration_date: The restricted stock units vest over four years, with 25% vesting on the first anniversary of the grant date and the remaining units vesting in equal quarterly installments thereafter. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 21:41 UTC |
BARRY JAMESEVP, President, LSG
|
Exercise / conversionRestricted Stock Units · Derivative | 251 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0002022345-26-000002 · wk-form4_1788471671.xml · derivative · entry 4 BARRY JAMES · CIK 0002022345 · EVP, President, LSG 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 251 Underlying: Bio-Rad A Common Stock · 251 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F4 · derivative.exercise_date: On September 1, 2023, the reporting person was granted 1,002 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F4 · derivative.expiration_date: On September 1, 2023, the reporting person was granted 1,002 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 21:41 UTC |
BARRY JAMESEVP, President, LSG
|
Exercise / conversionRestricted Stock Units · Derivative | 174 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0002022345-26-000002 · wk-form4_1788471671.xml · derivative · entry 3 BARRY JAMES · CIK 0002022345 · EVP, President, LSG 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Bio-Rad A Common Stock · 174 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F3 · derivative.exercise_date: On September 1, 2022, the reporting person was granted 694 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F3 · derivative.expiration_date: On September 1, 2022, the reporting person was granted 694 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 21:41 UTC |
BARRY JAMESEVP, President, LSG
|
Tax withholdingBio-Rad A Common Stock | 154 | $380.96 | $58,667.84 |
DisclosureSEC source: 0002022345-26-000002 · wk-form4_1788471671.xml · nonDerivative · entry 2 BARRY JAMES · CIK 0002022345 · EVP, President, LSG 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 780.682 Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 21:41 UTC |
BARRY JAMESEVP, President, LSG
|
Exercise / conversionBio-Rad A Common Stock | 425 | $0.00 | $0.00 |
DisclosureSEC source: 0002022345-26-000002 · wk-form4_1788471671.xml · nonDerivative · entry 1 BARRY JAMES · CIK 0002022345 · EVP, President, LSG 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 934.682 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 21:38 UTC |
Allison SchwartzDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 75 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001924980-26-000002 · wk-form4_1788471514.xml · derivative · entry 4 Allison Schwartz · CIK 0001924980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75 Underlying: Bio-Rad A Common Stock · 75 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F4 · derivative.exercise_date: On September 1, 2023, the reporting person was granted 298 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F4 · derivative.expiration_date: On September 1, 2023, the reporting person was granted 298 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 21:38 UTC |
Allison SchwartzDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 42 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001924980-26-000002 · wk-form4_1788471514.xml · derivative · entry 3 Allison Schwartz · CIK 0001924980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Bio-Rad A Common Stock · 42 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F3 · derivative.exercise_date: On September 1, 2022, the reporting person was granted 167 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F3 · derivative.expiration_date: On September 1, 2022, the reporting person was granted 167 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 21:38 UTC |
Allison SchwartzDirector
|
Tax withholdingBio-Rad A Common Stock | 43 | $380.96 | $16,381.28 |
DisclosureSEC source: 0001924980-26-000002 · wk-form4_1788471514.xml · nonDerivative · entry 2 Allison Schwartz · CIK 0001924980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,530 Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 21:38 UTC |
Allison SchwartzDirector
|
Exercise / conversionBio-Rad A Common Stock | 117 | $0.00 | $0.00 |
DisclosureSEC source: 0001924980-26-000002 · wk-form4_1788471514.xml · nonDerivative · entry 1 Allison Schwartz · CIK 0001924980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,573 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 21:35 UTC |
SCHWARTZ NORMAN DDirector · Chairman & CEO · 10% owner
|
Exercise / conversionRestricted Stock Units · Derivative | 3,005 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000940805-26-000002 · wk-form4_1788471355.xml · derivative · entry 14 SCHWARTZ NORMAN D · CIK 0000940805 · Director · Chairman & CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,005 Underlying: Bio-Rad A Common Stock · 3,005 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F7 · derivative.exercise_date: On September 1, 2023, the reporting person was granted 12,020 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F7 · derivative.expiration_date: On September 1, 2023, the reporting person was granted 12,020 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 21:35 UTC |
SCHWARTZ NORMAN DDirector · Chairman & CEO · 10% owner
|
Exercise / conversionRestricted Stock Units · Derivative | 2,082 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000940805-26-000002 · wk-form4_1788471355.xml · derivative · entry 13 SCHWARTZ NORMAN D · CIK 0000940805 · Director · Chairman & CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Bio-Rad A Common Stock · 2,082 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F6 · derivative.exercise_date: On September 1, 2022, the reporting person was granted 8,326 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F6 · derivative.expiration_date: On September 1, 2022, the reporting person was granted 8,326 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 21:35 UTC |
SCHWARTZ NORMAN DDirector · Chairman & CEO · 10% owner
|
Tax withholdingBio-Rad A Common Stock | 2,336 | $380.96 | $889,922.56 |
DisclosureSEC source: 0000940805-26-000002 · wk-form4_1788471355.xml · nonDerivative · entry 2 SCHWARTZ NORMAN D · CIK 0000940805 · Director · Chairman & CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 446,185 Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 21:35 UTC |
SCHWARTZ NORMAN DDirector · Chairman & CEO · 10% owner
|
Exercise / conversionBio-Rad A Common Stock | 5,087 | $0.00 | $0.00 |
DisclosureSEC source: 0000940805-26-000002 · wk-form4_1788471355.xml · nonDerivative · entry 1 SCHWARTZ NORMAN D · CIK 0000940805 · Director · Chairman & CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 448,521 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| July 25, 2026 Filed Jul 28, 2026 19:05 UTC |
ENGELHARDT EVA ANETTEEVP, President, CDG
|
Exercise / conversionRestricted Stock Units · Derivative | 246 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0002024911-26-000004 · wk-form4_1785265542.xml · derivative · entry 3 ENGELHARDT EVA ANETTE · CIK 0002024911 · EVP, President, CDG 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 492 Underlying: Bio-Rad A Common Stock · 246 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F3 · derivative.exercise_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. F3 · derivative.expiration_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. Read SEC document |
| July 25, 2026 Filed Jul 28, 2026 19:05 UTC |
ENGELHARDT EVA ANETTEEVP, President, CDG
|
Tax withholdingBio-Rad A Common Stock | 89 | $314.46 | $27,986.94 |
DisclosureSEC source: 0002024911-26-000004 · wk-form4_1785265542.xml · nonDerivative · entry 2 ENGELHARDT EVA ANETTE · CIK 0002024911 · EVP, President, CDG 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 503 Read SEC document |
| July 25, 2026 Filed Jul 28, 2026 19:05 UTC |
ENGELHARDT EVA ANETTEEVP, President, CDG
|
Exercise / conversionBio-Rad A Common Stock | 246 | $0.00 | $0.00 |
DisclosureSEC source: 0002024911-26-000004 · wk-form4_1785265542.xml · nonDerivative · entry 1 ENGELHARDT EVA ANETTE · CIK 0002024911 · EVP, President, CDG 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 592 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| May 11, 2026 Filed May 13, 2026 19:38 UTC |
ENGELHARDT EVA ANETTEEVP, President, CDG
|
SaleBio-Rad A Common Stock | 550 | $246.54 | $135,597.00 |
DisclosureSEC source: 0002024911-26-000002 · wk-form4_1778701106.xml · nonDerivative · entry 1 ENGELHARDT EVA ANETTE · CIK 0002024911 · EVP, President, CDG 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 346 Read SEC document |
| April 24, 2026 Filed Apr 28, 2026 16:21 UTC |
Lakkaraju Roop KalyanEVP, Chief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,078 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001396867-26-000002 · wk-form4_1777393306.xml · derivative · entry 3 Lakkaraju Roop Kalyan · CIK 0001396867 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,156 Underlying: Bio-Rad A Common Stock · 1,078 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F4 · derivative.exercise_date: On April 24, 2024, the reporting person was granted 4,311 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F4 · derivative.expiration_date: On April 24, 2024, the reporting person was granted 4,311 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| April 24, 2026 Filed Apr 28, 2026 16:21 UTC |
Lakkaraju Roop KalyanEVP, Chief Financial Officer
|
Tax withholdingBio-Rad A Common Stock | 420 | $287.84 | $120,892.80 |
DisclosureSEC source: 0001396867-26-000002 · wk-form4_1777393306.xml · nonDerivative · entry 2 Lakkaraju Roop Kalyan · CIK 0001396867 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,563.895 Read SEC document |
| April 24, 2026 Filed Apr 28, 2026 16:21 UTC |
Lakkaraju Roop KalyanEVP, Chief Financial Officer
|
Exercise / conversionBio-Rad A Common Stock | 1,078 | $0.00 | $0.00 |
DisclosureSEC source: 0001396867-26-000002 · wk-form4_1777393306.xml · nonDerivative · entry 1 Lakkaraju Roop Kalyan · CIK 0001396867 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,983.895 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. F2 · balance_after: Includes 62.2360 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 03/31/2026. Read SEC document |
| April 24, 2026 Filed Apr 28, 2026 16:20 UTC |
ENLOE COURTNEY CEVP, General Counsel & Sec
|
Exercise / conversionRestricted Stock Units · Derivative | 186 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0002019843-26-000002 · wk-form4_1777393201.xml · derivative · entry 3 ENLOE COURTNEY C · CIK 0002019843 · EVP, General Counsel & Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 372 Underlying: Bio-Rad A Common Stock · 186 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F4 · derivative.exercise_date: On April 24, 2024, the reporting person was granted 744 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F4 · derivative.expiration_date: On April 24, 2024, the reporting person was granted 744 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| April 24, 2026 Filed Apr 28, 2026 16:20 UTC |
ENLOE COURTNEY CEVP, General Counsel & Sec
|
Tax withholdingBio-Rad A Common Stock | 77 | $287.84 | $22,163.68 |
DisclosureSEC source: 0002019843-26-000002 · wk-form4_1777393201.xml · nonDerivative · entry 2 ENLOE COURTNEY C · CIK 0002019843 · EVP, General Counsel & Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 749.777 Read SEC document |
| April 24, 2026 Filed Apr 28, 2026 16:20 UTC |
ENLOE COURTNEY CEVP, General Counsel & Sec
|
Exercise / conversionBio-Rad A Common Stock | 186 | $0.00 | $0.00 |
DisclosureSEC source: 0002019843-26-000002 · wk-form4_1777393201.xml · nonDerivative · entry 1 ENLOE COURTNEY C · CIK 0002019843 · EVP, General Counsel & Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 826.777 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. F2 · balance_after: Includes 6.1520 and 5.6340 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 09/30/2025 and 12/31/2025, respectively. Read SEC document |
| April 21, 2026 Filed Apr 23, 2026 19:26 UTC |
Hinckley Greg KDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 407 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001239182-26-000003 · wk-form4_1776972385.xml · derivative · entry 3 Hinckley Greg K · CIK 0001239182 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Bio-Rad A Common Stock · 407 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F3 · derivative.exercise_date: The restricted stock units will vest 100% on the earlier of the first anniversary of the grant date or the date of the company's next annual meeting of stockholders. F3 · derivative.expiration_date: The restricted stock units will vest 100% on the earlier of the first anniversary of the grant date or the date of the company's next annual meeting of stockholders. Read SEC document |
| April 21, 2026 Filed Apr 23, 2026 19:26 UTC |
Hinckley Greg KDirector
|
GrantRestricted Stock Units · Derivative | 369 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001239182-26-000003 · wk-form4_1776972385.xml · derivative · entry 2 Hinckley Greg K · CIK 0001239182 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 369 Underlying: Bio-Rad A Common Stock · 369 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F3 · derivative.exercise_date: The restricted stock units will vest 100% on the earlier of the first anniversary of the grant date or the date of the company's next annual meeting of stockholders. F3 · derivative.expiration_date: The restricted stock units will vest 100% on the earlier of the first anniversary of the grant date or the date of the company's next annual meeting of stockholders. Read SEC document |
| April 21, 2026 Filed Apr 23, 2026 19:26 UTC |
Hinckley Greg KDirector
|
Exercise / conversionBio-Rad A Common Stock | 407 | $0.00 | $0.00 |
DisclosureSEC source: 0001239182-26-000003 · wk-form4_1776972385.xml · nonDerivative · entry 1 Hinckley Greg K · CIK 0001239182 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,215 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| April 21, 2026 Filed Apr 23, 2026 19:25 UTC |
PEI MELINDA LITHERLANDDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 407 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001703469-26-000002 · wk-form4_1776972330.xml · derivative · entry 3 PEI MELINDA LITHERLAND · CIK 0001703469 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Bio-Rad A Common Stock · 407 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F3 · derivative.exercise_date: The restricted stock units will vest 100% on the earlier of the first anniversary of the grant date or the date of the company's next annual meeting of stockholders. F3 · derivative.expiration_date: The restricted stock units will vest 100% on the earlier of the first anniversary of the grant date or the date of the company's next annual meeting of stockholders. Read SEC document |
| April 21, 2026 Filed Apr 23, 2026 19:25 UTC |
PEI MELINDA LITHERLANDDirector
|
GrantRestricted Stock Units · Derivative | 369 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001703469-26-000002 · wk-form4_1776972330.xml · derivative · entry 2 PEI MELINDA LITHERLAND · CIK 0001703469 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 369 Underlying: Bio-Rad A Common Stock · 369 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F3 · derivative.exercise_date: The restricted stock units will vest 100% on the earlier of the first anniversary of the grant date or the date of the company's next annual meeting of stockholders. F3 · derivative.expiration_date: The restricted stock units will vest 100% on the earlier of the first anniversary of the grant date or the date of the company's next annual meeting of stockholders. Read SEC document |
| April 21, 2026 Filed Apr 23, 2026 19:25 UTC |
PEI MELINDA LITHERLANDDirector
|
Exercise / conversionBio-Rad A Common Stock | 407 | $0.00 | $0.00 |
DisclosureSEC source: 0001703469-26-000002 · wk-form4_1776972330.xml · nonDerivative · entry 1 PEI MELINDA LITHERLAND · CIK 0001703469 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 715 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| April 21, 2026 Filed Apr 23, 2026 19:24 UTC |
EDWARDS JEFFREY LDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 407 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001190642-26-000002 · wk-form4_1776972296.xml · derivative · entry 3 EDWARDS JEFFREY L · CIK 0001190642 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Bio-Rad A Common Stock · 407 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F3 · derivative.exercise_date: The restricted stock units will vest 100% on the earlier of the first anniversary of the grant date or the date of the company's next annual meeting of stockholders. F3 · derivative.expiration_date: The restricted stock units will vest 100% on the earlier of the first anniversary of the grant date or the date of the company's next annual meeting of stockholders. Read SEC document |
| April 21, 2026 Filed Apr 23, 2026 19:24 UTC |
EDWARDS JEFFREY LDirector
|
GrantRestricted Stock Units · Derivative | 369 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001190642-26-000002 · wk-form4_1776972296.xml · derivative · entry 2 EDWARDS JEFFREY L · CIK 0001190642 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 369 Underlying: Bio-Rad A Common Stock · 369 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F3 · derivative.exercise_date: The restricted stock units will vest 100% on the earlier of the first anniversary of the grant date or the date of the company's next annual meeting of stockholders. F3 · derivative.expiration_date: The restricted stock units will vest 100% on the earlier of the first anniversary of the grant date or the date of the company's next annual meeting of stockholders. Read SEC document |
| April 21, 2026 Filed Apr 23, 2026 19:24 UTC |
EDWARDS JEFFREY LDirector
|
Exercise / conversionBio-Rad A Common Stock | 407 | $0.00 | $0.00 |
DisclosureSEC source: 0001190642-26-000002 · wk-form4_1776972296.xml · nonDerivative · entry 1 EDWARDS JEFFREY L · CIK 0001190642 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 715 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| April 21, 2026 Filed Apr 23, 2026 19:23 UTC |
PINKSTON ARNOLD ADirector
|
Exercise / conversionRestricted Stock Units · Derivative | 407 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001343989-26-000002 · wk-form4_1776972221.xml · derivative · entry 3 PINKSTON ARNOLD A · CIK 0001343989 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Bio-Rad A Common Stock · 407 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F3 · derivative.exercise_date: The restricted stock units will vest 100% on the earlier of the first anniversary of the grant date or the date of the company's next annual meeting of stockholders. F3 · derivative.expiration_date: The restricted stock units will vest 100% on the earlier of the first anniversary of the grant date or the date of the company's next annual meeting of stockholders. Read SEC document |
| April 21, 2026 Filed Apr 23, 2026 19:23 UTC |
PINKSTON ARNOLD ADirector
|
GrantRestricted Stock Units · Derivative | 369 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001343989-26-000002 · wk-form4_1776972221.xml · derivative · entry 2 PINKSTON ARNOLD A · CIK 0001343989 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 369 Underlying: Bio-Rad A Common Stock · 369 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F3 · derivative.exercise_date: The restricted stock units will vest 100% on the earlier of the first anniversary of the grant date or the date of the company's next annual meeting of stockholders. F3 · derivative.expiration_date: The restricted stock units will vest 100% on the earlier of the first anniversary of the grant date or the date of the company's next annual meeting of stockholders. Read SEC document |
| April 21, 2026 Filed Apr 23, 2026 19:23 UTC |
PINKSTON ARNOLD ADirector
|
Exercise / conversionBio-Rad A Common Stock | 407 | $0.00 | $0.00 |
DisclosureSEC source: 0001343989-26-000002 · wk-form4_1776972221.xml · nonDerivative · entry 1 PINKSTON ARNOLD A · CIK 0001343989 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 715 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| November 06, 2025 Filed Nov 10, 2025 21:15 UTC |
BARRY JAMESEVP, President, LSG
|
SaleBio-Rad A Common Stock | 699.873 | $306.18 | $214,288.51 |
DisclosureSEC source: 0002022345-25-000008 · wk-form4_1762809346.xml · nonDerivative · entry 1 BARRY JAMES · CIK 0002022345 · EVP, President, LSG 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 509.682 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $306.104 to $306.230, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 24, 2025 Filed Oct 28, 2025 16:29 UTC |
DiVincenzo Jonathan P.President & COO
|
Exercise / conversionRestricted Stock Units · Derivative | 1,869 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001453524-25-000007 · wk-form4_1761668981.xml · derivative · entry 3 DiVincenzo Jonathan P. · CIK 0001453524 · President & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,609 Underlying: Bio-Rad A Common Stock · 1,869 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F3 · derivative.exercise_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. F3 · derivative.expiration_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. Read SEC document |
| October 24, 2025 Filed Oct 28, 2025 16:29 UTC |
DiVincenzo Jonathan P.President & COO
|
Tax withholdingBio-Rad A Common Stock | 950 | $339.75 | $322,762.50 |
DisclosureSEC source: 0001453524-25-000007 · wk-form4_1761668981.xml · nonDerivative · entry 2 DiVincenzo Jonathan P. · CIK 0001453524 · President & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 919 Read SEC document |
| October 24, 2025 Filed Oct 28, 2025 16:29 UTC |
DiVincenzo Jonathan P.President & COO
|
Exercise / conversionBio-Rad A Common Stock | 1,869 | $0.00 | $0.00 |
DisclosureSEC source: 0001453524-25-000007 · wk-form4_1761668981.xml · nonDerivative · entry 1 DiVincenzo Jonathan P. · CIK 0001453524 · President & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,869 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| October 20, 2025 Filed Oct 21, 2025 20:42 UTC |
EVRAN SEDATEVP, Global Supply Chain
|
Exercise / conversionRestricted Stock Units · Derivative | 1,044 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001993147-25-000006 · wk-form4_1761079318.xml · derivative · entry 3 EVRAN SEDAT · CIK 0001993147 · EVP, Global Supply Chain 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,088 Underlying: Bio-Rad A Common Stock · 1,044 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F3 · derivative.exercise_date: On October 20, 2023, the reporting person was granted 4,176 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F3 · derivative.expiration_date: On October 20, 2023, the reporting person was granted 4,176 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| October 20, 2025 Filed Oct 21, 2025 20:42 UTC |
EVRAN SEDATEVP, Global Supply Chain
|
Tax withholdingBio-Rad A Common Stock | 335 | $321.90 | $107,836.50 |
DisclosureSEC source: 0001993147-25-000006 · wk-form4_1761079318.xml · nonDerivative · entry 2 EVRAN SEDAT · CIK 0001993147 · EVP, Global Supply Chain 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,232.847 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.